X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Cadila Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs CADILA HEALTHCARE - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

CADILA HEALTHCARE 
   Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT CADILA HEALTHCARE WOCKHARDT/
CADILA HEALTHCARE
 
P/E (TTM) x -19.1 12.9 - View Chart
P/BV x 1.3 2.7 49.4% View Chart
Dividend Yield % 0.0 1.5 0.2%  

Financials

 WOCKHARDT   CADILA HEALTHCARE
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
CADILA HEALTHCARE
Mar-18
WOCKHARDT/
CADILA HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,012558 181.4%   
Low Rs532362 147.0%   
Sales per share (Unadj.) Rs355.9116.3 306.0%  
Earnings per share (Unadj.) Rs-60.317.9 -337.4%  
Cash flow per share (Unadj.) Rs-46.823.1 -202.2%  
Dividends per share (Unadj.) Rs0.013.50 0.3%  
Dividend yield (eoy) %00.8 0.2%  
Book value per share (Unadj.) Rs257.885.4 301.8%  
Shares outstanding (eoy) m110.631,023.74 10.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.24.0 54.9%   
Avg P/E ratio x-12.825.7 -49.8%  
P/CF ratio (eoy) x-16.519.9 -83.0%  
Price / Book Value ratio x3.05.4 55.6%  
Dividend payout %019.6 -0.1%   
Avg Mkt Cap Rs m85,379470,664 18.1%   
No. of employees `0006.311.8 52.9%   
Total wages/salary Rs m9,37118,545 50.5%   
Avg. sales/employee Rs Th6,295.010,072.7 62.5%   
Avg. wages/employee Rs Th1,498.31,569.1 95.5%   
Avg. net profit/employee Rs Th-1,066.31,547.7 -68.9%   
INCOME DATA
Net Sales Rs m39,369119,049 33.1%  
Other income Rs m1,2021,132 106.2%   
Total revenues Rs m40,571120,181 33.8%   
Gross profit Rs m1828,475 0.1%  
Depreciation Rs m1,4955,388 27.8%   
Interest Rs m2,555911 280.5%   
Profit before tax Rs m-2,83023,308 -12.1%   
Minority Interest Rs m0628 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m2575,644 4.6%   
Profit after tax Rs m-6,66918,292 -36.5%  
Gross profit margin %023.9 0.2%  
Effective tax rate %-9.124.2 -37.5%   
Net profit margin %-16.915.4 -110.2%  
BALANCE SHEET DATA
Current assets Rs m33,79682,005 41.2%   
Current liabilities Rs m26,91760,720 44.3%   
Net working cap to sales %17.517.9 97.7%  
Current ratio x1.31.4 93.0%  
Inventory Days Days7973 108.5%  
Debtors Days Days8998 90.8%  
Net fixed assets Rs m39,66483,703 47.4%   
Share capital Rs m5531,024 54.0%   
"Free" reserves Rs m27,96886,421 32.4%   
Net worth Rs m28,52287,445 32.6%   
Long term debt Rs m21,73125,551 85.0%   
Total assets Rs m81,620180,653 45.2%  
Interest coverage x-0.126.6 -0.4%   
Debt to equity ratio x0.80.3 260.8%  
Sales to assets ratio x0.50.7 73.2%   
Return on assets %-5.010.6 -47.4%  
Return on equity %-23.420.9 -111.8%  
Return on capital %-7.722.0 -34.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,80742,683 23.0%   
Fx outflow Rs m1,78911,242 15.9%   
Net fx Rs m8,01931,441 25.5%   
CASH FLOW
From Operations Rs m6849,193 7.4%  
From Investments Rs m6,302-9,737 -64.7%  
From Financial Activity Rs m-7,695515 -1,494.1%  
Net Cashflow Rs m-664-29 2,289.7%  

Share Holding

Indian Promoters % 74.5 74.8 99.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 8.3 27.7%  
FIIs % 7.7 5.9 130.5%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 11.0 140.0%  
Shareholders   67,757 44,069 153.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare WOCKHARDT With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jul 18, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WOCKHARDT 8-QTR ANALYSIS

COMPARE WOCKHARDT WITH

MARKET STATS